PlainRecalls
FDA Drug Moderate Class II Terminated

INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960

Reported: May 21, 2014 Initiated: March 24, 2014 #D-1295-2014

Product Description

INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960

Reason for Recall

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
5812 bottles
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. Recalled by Teva Pharmaceuticals USA. Units affected: 5812 bottles.
Why was this product recalled?
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 21, 2014. Severity: Moderate. Recall number: D-1295-2014.